Delayed Intratumoral Hemorrhage after Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma
Transarterial chemoembolization (TACE) using a drug-eluting bead (DEB-TACE) for hepatocellular carcinoma (HCC) is a new treatment method. We report on a case of delayed intratumoral hemorrhage after DEB-TACE. An 81-year-old male with hepatitis C virus-related cirrhosis was diagnosed with a HCC of 35...
Auteurs principaux: | Kazue Shiozawa, Manabu Watanabe, Takashi Ikehara, Yu Ogino, Tomoko Umakoshi, Yasushi Matsukiyo, Michio Kogame, Teppei Matsui, Yoshinori Kikuchi, Yoshinori Igarashi, Yasukiyo Sumino |
---|---|
Format: | Article |
Langue: | English |
Publié: |
Karger Publishers
2014-11-01
|
Collection: | Case Reports in Oncology |
Sujets: | |
Accès en ligne: | http://www.karger.com/Article/FullText/369005 |
Documents similaires
-
Role of drug-eluting beads versus conventional transarterial chemoembolization in the treatment of hepatocellular carcinoma
par: Mahmoud Abu Elfadl, et autres
Publié: (2019-01-01) -
Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Apatinib Compared with Conventional Transarterial Chemoembolization Plus Apatinib in the Treatment of Unresectable Hepatocellular Carcinoma
par: Zhang W, et autres
Publié: (2021-07-01) -
Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future
par: Hyun Young Woo, et autres
Publié: (2015-12-01) -
The impact of drug-eluting bead (vs. conventional) transarterial chemoembolization on hepatic fibrosis in treating intermediate or advanced hepatocellular carcinoma
par: Hao Li, et autres
Publié: (2023-12-01) -
Conventional and drug‑eluting bead transarterial chemoembolization in patients with inoperable intrahepatic cholangiocarcinoma: a meta‑analysis
par: Su-Rong Pan, et autres
Publié: (2024-11-01)